表紙
市場調查報告書

失禁用產品及造口術市場 - 成長,趨勢,及預測(2019年 - 2024年)

Incontinence Devices and Ostomy Market - Growth, Trends, and Forecast (2019 - 2024)

出版商 Mordor Intelligence LLP 商品編碼 871457
出版日期 內容資訊 英文 115 Pages
商品交期: 2-3個工作天內
價格
Back to Top
失禁用產品及造口術市場 - 成長,趨勢,及預測(2019年 - 2024年) Incontinence Devices and Ostomy Market - Growth, Trends, and Forecast (2019 - 2024)
出版日期: 2019年06月01日內容資訊: 英文 115 Pages
簡介

全球失禁用產品及造口術市場在2019年∼2024年間,預測將以10.1%的年複合成長率成長。市場成長要素,有老年人和肥胖者的增加,腎臟疾病和腎臟障礙的盛行率增加,造口術照護產品的接收等。

本報告提供全球失禁用產品及造口術市場的相關調查,市場概況和成長要素、阻礙因素,各產品類型、用途、地區的市場分析,競爭情形,主要企業的簡介等資訊彙整。

目錄

第1章 簡介

  • 研究成果
  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 市場成長要素
    • 老年人口及肥胖人口的增加
    • 腎臟病及腎臟障礙的罹患率增加
    • 造口術照護產品相關的意識高漲與接受
  • 市場阻礙因素
    • 缺乏適當的償付
    • 造口術和失禁用產品的使用伴隨的併發症
  • 波特五力分析
    • 新加入廠商的威脅
    • 買主/消費者談判力
    • 供應商談判力
    • 替代產品的威脅
    • 產業內的競爭

第5章 市場區隔

  • 產品的種類
    • 失禁護理產品
    • 造口術照護產品
  • 用途
    • 膀胱癌
    • 大腸癌症
    • 克隆氏症
    • 腎臟結石
    • 慢性腎衰竭
    • 其他的用途
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東和非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Abena AS
    • B. Braun Melsungen AG
    • Coloplast Corporation
    • ConvaTec
    • Hollister Inc.
    • Kimberly-Clark Corporation
    • Salts Healthcare
    • SCA (Svenska Cellulosa Aktiebolaget)
    • Unicharm Corporation

第7章 市場機會及今後趨勢

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 57125

Market Overview

Global Incontinence Devices and Ostomy market are expected to witness a CAGR of 10.1% during the forecast period. Certain factors that are driving the market growth include the rise in geriatric and obese population, increasing the prevalence of renal diseases and nephrological injuries, growing awareness, and acceptance regarding ostomy care products.

Excretions by the kidney, in urine form, may vary drastically and cause variations in the urinary pH and composition, leading to urinary incontinence (UI) problems. Adult diapers are significantly necessary in such cases, including mobility impairment, severe diarrhea, or dementia. Decreased renal function, primarily age-related, is one of the major indicators of chronic diseases, which may be accelerated, due to several chronic diseases, such as hypertension, diabetes, and obesity among other diseases, often leading to different stages of kidney diseases. These diseases are health burdens, globally, with high economic costs to health systems. The recently published research data by the World Health Organization (WHO) validates the huge demand for incontinence products. As per the WHO, Integrated Care for Older People (ICOPE) guidelines and specific population-based studies released in 2017, the global prevalence of UI was observed to be in the range of 8.9% to 36.1%, in different patient pools.

However, common complications associated with ostomy surgery include skin irritation, diarrhea, short bowel syndrome, and bleeding. Most of these complications can be managed by taking appropriate care, pharmaceutical supplementation, and using additional ostomy care products, such as barrier ointment and ostomy powders. In addition, ostomy procedures are sometimes associated with more critical complications, such as infections, blockage, and stoma problems, such as hernia, prolapse, and narrowing of the stoma. In the case of urinary catheter usage, the infections associated with it are high, owing to bacterial colonization and mucosal irritation. Catheter-associated Urinary Tract Infection (CAUTI) has been primarily related to increased morbidity, mortality, healthcare costs, and length of stay in hospitals. Thus, complications associated with ostomy and usage of incontinence products are the major restraints in the market, as they may lead to other complications, such as prostatitis, epididymitis, and orchitis.

Scope of the Report

Ostomy surgery is a procedure that allows bodily waste to pass through a surgically created stoma on the abdomen. The ostomy care products such as skin barriers and ostomy bags provide means for the collection of waste from a surgically diverted biological system. In incontinence, there is a lack of voluntary release of contents from the urinary bladder muscles, for which, a range of disposable incontinence products (DIP) is manufactured by leading global medical device companies.

Key Market Trends

Colorectal Cancer is Expected to Observe Lucrative Growth in the Application Segment

Colorectal cancer has one of the highest incidence rates and prevalence rates of all cancers, worldwide. Primary causes of colorectal cancer are said to be lifestyle disorders, aging, and diet. According to a 2016 research article published in Journal of investigative medicine by Abhishek Bhandari et al., it was estimated that colorectal cancer (CRC) accounted for over 9% of all cancer incidences and is a major cause of morbidity and mortality throughout the world. According to the World Health Organization (WHO) estimates, an increase of around 70% is expected in the colorectal cancer prevalence, by 2030. Colorectal cancer is a leading cause of both temporary and permanent ileostomy and colostomy procedures.

North America Dominates the Market and is Expected to do Same in the Forecast Period

According to the Crohn's & Colitis Foundation, there are about 1.6 million Americans that have inflammatory bowel disease (IBD). This figure includes about 780,000 people with Crohn's disease and another 907,000 with ulcerative colitis. The researchers have estimated that there are 6 to 15 new cases of Crohn's disease that are diagnosed per 100,000 people each year. Several studies have indicated that Crohn's disease is becoming more common in children and adults in the United States. Incontinence is a prevalent health condition, with a significant proportion of the population suffering from it. However, it is rarely discussed, as in most of the cases people are embarrassed to do so. Urinary incontinence is primarily associated with aging, affecting up to 30% of elderly people. It occurs in 85% of long-term-care patients and is often the reason for admission to these facilities. Several companies share a strong retail presence, across the region, with their products, which are useful for mobile adults living at home care, hospitals, and institutions, such as Kimberly-Clark and Svenska Cellulosa Aktiebolaget (SCA) among others.

Competitive Landscape

The global Incontinence Devices and Ostomymarket is highly competitive and consists of a number of major players. Companies like Abena AS, B. Braun Melsungen AG, Coloplast Corporation, ConvaTec, Hollister Inc., Kimberly-Clark Corporation, Salts Healthcare, SCA (Svenska Cellulosa Aktiebolaget), Unicharm Corporation, among others, hold the substantial market share in the Incontinence Devices and Ostomy market.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rise in Geriatric and Obese Population
    • 4.2.2 Increasing Prevalence of Renal Diseases and Nephrological Injuries
    • 4.2.3 Growing Awareness and Acceptance regarding Ostomy Care Products
  • 4.3 Market Restraints
    • 4.3.1 Lack of Proper Reimbursement
    • 4.3.2 Complications Associated with Ostomy and Usage of Incontinence Products
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 Product Type
    • 5.1.1 Incontinence Care Products
      • 5.1.1.1 Absorbents
      • 5.1.1.2 Incontinence Bags
      • 5.1.1.3 Others (clamps, deodorizers, cleaners, urinals etc.)
    • 5.1.2 Ostomy Care Products
      • 5.1.2.1 Ostomy Bags
      • 5.1.2.1.1 Colostomy Bags
      • 5.1.2.1.2 Ileostomy Bags
      • 5.1.2.1.3 Urostomy Bags
      • 5.1.2.2 Deodorants
      • 5.1.2.3 Skin Barriers
      • 5.1.2.4 Irrigation Products
      • 5.1.2.5 Others
  • 5.2 Application
    • 5.2.1 Bladder Cancer
    • 5.2.2 Colorectal Cancer
    • 5.2.3 Crohn's Disease
    • 5.2.4 Kidney Stone
    • 5.2.5 Chronic Kidney Failure
    • 5.2.6 Other Applications
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 US
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 UK
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abena AS
    • 6.1.2 B. Braun Melsungen AG
    • 6.1.3 Coloplast Corporation
    • 6.1.4 ConvaTec
    • 6.1.5 Hollister Inc.
    • 6.1.6 Kimberly-Clark Corporation
    • 6.1.7 Salts Healthcare
    • 6.1.8 SCA (Svenska Cellulosa Aktiebolaget)
    • 6.1.9 Unicharm Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top